For some cancer subtypes, such as triple-negative breast cancer, there are no specific
therapies, which leads to a poor prognosis associated with invasion and metastases …

Anticancer potential of ruthenium complexes has been widely investigated, but safety
evaluation studies are still scarce. Despite of ruthenium-based anticancer agents are known …

In this paper, four new ruthenium complexes,[Ru (N–S)(dppm) 2] PF6 (1),[Ru (N–S)(dppe) 2]
PF6 (2),[Ru (N–S) 2 (dppp)](3) and [Ru (N–S) 2 (PPh3) 2](4)[dppm= 1, 1-bis …

Thirteen new ruthenium amino acid complexes were synthesized and characterized. They
were obtained by the reaction of α-amino acids (AA) with [RuCl 2 (PP)(NN)], where PP= 1, 4 …

This study performed in vitro and in vivo biological assays of the ruthenium (II) compound ct-
[RuCl (CO)(dppb)(bipy)] PF 6 (where, dppb= 1, 4-bis (diphenylphosphine) butane and bipy …

Non-small cell lung cancer (NSCLC) is the most common cancer worldwide, which is related
with poor prognosis and resistance to chemotherapy. Notably, ruthenium-based complexes …

Ruthenium complexes are being considered as novel chemotherapeutic alternatives for
cancer treatment. In our study, we assessed the antitumoral activities of novel ruthenium …

In the current research, based on the investigation of the drug-loaded hydrogels, the
maximum content of acyclovir loading in polymer consequently relates to the pH at which the …

Peritoneal carcinomatosis is considered as a potentially lethal clinical condition, and the
therapeutic options are limited. The antitumor effectiveness of the [Ru (l-Met)(bipy)(dppb)] …

The number of cancer cases continues to increase worldwide, and unfortunately the main
systemic treatments available have numerous of side effects. Ruthenium complexes have …